Distribuzione geografica
Continente #
NA - Nord America 678
EU - Europa 209
AS - Asia 18
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 911
Nazione #
US - Stati Uniti d'America 673
IT - Italia 80
DE - Germania 61
BE - Belgio 10
FI - Finlandia 8
NL - Olanda 8
SE - Svezia 8
SG - Singapore 8
UA - Ucraina 7
CA - Canada 5
PL - Polonia 5
CZ - Repubblica Ceca 4
FR - Francia 4
GB - Regno Unito 4
IR - Iran 4
NO - Norvegia 4
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
GR - Grecia 2
ID - Indonesia 2
RO - Romania 2
AU - Australia 1
CH - Svizzera 1
ES - Italia 1
HK - Hong Kong 1
IN - India 1
KR - Corea 1
MY - Malesia 1
Totale 911
Città #
Chandler 161
Ashburn 76
Munich 50
Boardman 36
Lawrence 26
Princeton 26
Miami 17
Seattle 13
Brussels 10
Phoenix 9
Helsinki 8
Milan 7
Amsterdam 5
Singapore 5
Borås 4
Frankfurt am Main 4
Las Vegas 4
Olomouc 4
Rockville 4
Verona 4
Warsaw 4
West Jordan 4
Asker 3
Chicago 3
Dunedin 3
Calgary 2
Chapel Hill 2
Enfield 2
Huizen 2
La Canada Flintridge 2
Noicattaro 2
Pekanbaru 2
Torslanda 2
Bethesda 1
Birmingham 1
Buffalo 1
Champaign 1
Collegno 1
Iasi 1
Kuantan 1
Naples 1
Nuremberg 1
Rasht 1
Rome 1
San Miniato Basso 1
Stockholm 1
Sydney 1
Thessaloníki 1
Trento 1
Vimercate 1
Wuppertal 1
Yeongdeungpo-gu 1
Zgierz 1
Totale 526
Nome #
Mapping the human genetic architecture of COVID-19 76
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes 44
A GWAS meta-analysis from 5 population-based cohorts implicates ion channel genes in the pathogenesis of irritable bowel syndrome 29
Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome 29
Large-scale association analyses identify host factors influencing human gut microbiome composition 27
Association of TNFSF15 polymorphism with irritable bowel syndrome 27
Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts 26
Fecal Biomarkers of Neutrophil and Eosinophil Origin Reflect the Response to Biological Therapy and Corticosteroids in Patients With Inflammatory Bowel Disease 25
Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome Patients 25
A second update on mapping the human genetic architecture of COVID-19 24
Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders 24
Loss-of-Function of the Voltage-Gated Sodium Channel NaV1.5 (Channelopathies) in Patients With Irritable Bowel Syndrome 24
HLA Associations Distinguish Collagenous From Lymphocytic Colitis 24
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 24
Faecal microbiota composition associates with abdominal pain in the general population 23
TRPM8polymorphisms associated with increased risk of IBS-C and IBS-M 23
Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease 22
Fine-mapping inflammatory bowel disease loci to single-variant resolution 22
A GWAS meta-analysis suggests roles for xenobiotic metabolism and ion channel activity in the biology of stool frequency 22
Functional variants in the sucrase–isomaltase gene associate with increased risk of irritable bowel syndrome 21
C13orf31 (FAMIN) is a central regulator of immunometabolic function 21
Dense genotyping of immune-related loci identifies HLA variants associated with increased risk of collagenous colitis 20
Rare Hypomorphic Sucrase Isomaltase Variants in Relation to Irritable Bowel Syndrome Risk in UK Biobank 19
Genome-wide analysis of 944 133 individuals provides insights into the etiology of haemorrhoidal disease 19
Reduced efficacy of low FODMAPs diet in patients with IBS-D carrying sucrase-isomaltase (SI) hypomorphic variants 18
Sucrase-isomaltase 15Phe IBS risk variant in relation to dietary carbohydrates and faecal microbiota composition 17
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 16
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 16
Adult sucrase-isomaltase deficiency masquerading as IBS 15
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality 14
Neuropeptide S Receptor 1 Gene Polymorphism Is Associated With Susceptibility to Inflammatory Bowel Disease 14
A survey of functional dyspepsia in 361,360 individuals: Phenotypic and genetic cross-disease analyses 13
Multi-Omics Analyses Show Disease, Diet, and Transcriptome Interactions With the Virome 13
Association of Polygenic Risk Score and Bacterial Toxins at Screening Colonoscopy with Colorectal Cancer Progression: A Multicenter Case-Control Study 12
A Starch- and Sucrose-Reduced Diet in Irritable Bowel Syndrome Leads to Lower Circulating Levels of PAI-1 and Visfatin: A Randomized Controlled Study 11
miR-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom profile in irritable bowel syndrome 11
A starch- and sucrose-reduced dietary intervention in irritable bowel syndrome patients produced a shift in gut microbiota composition along with changes in phylum, genus, and amplicon sequence variant abundances, without affecting the micro-RNA levels 11
Microscopic colitis 10
Detailed Transcriptional Landscape of Peripheral Blood Points to Increased Neutrophil Activation in Treatment-Naïve Inflammatory Bowel Disease 10
Crohn's Disease Is Associated With Activation of Circulating Innate Lymphoid Cells 10
Genetics of irritable bowel syndrome: shifting gear via biobank-scale studies 10
Metabolic Profiling of Plasma in Patients with Irritable Bowel Syndrome after a 4-Week Starch- and Sucrose-Reduced Diet 9
Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis 9
Pathogenesis of Microscopic Colitis: A Systematic Review 9
Association Between Collagenous and Lymphocytic Colitis and Risk of Severe Coronavirus Disease 2019 9
Performance of the Use of Genetic Information to Assess the Risk of Colorectal Cancer in the Basque Population 8
Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease 8
GWAS of stool frequency provides insights into gastrointestinal motility and irritable bowel syndrome 8
Gastrointestinal Infection and Risk of Microscopic Colitis: A Nationwide Case-Control Study in Sweden 8
Systemic Inflammation in Preclinical Ulcerative Colitis 8
Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2 8
Neuropeptide S Receptor Induces Neuropeptide Expression and Associates With Intermediate Phenotypes of Functional Gastrointestinal Disorders 8
Applicability of polygenic risk scores in endometriosis clinical presentation 8
Analysis of Systemic Epigenetic Alterations in Inflammatory Bowel Disease: Defining Geographical, Genetic and Immune-Inflammatory influences on the Circulating Methylome 7
Genetics of irritable bowel syndrome 7
Clusters of community-dwelling individuals empirically derived from stool diaries correspond with clinically meaningful outcomes 7
A 1 year course of starch- and sucrose-reduced diet used by irritable bowel syndrome patients with diarrhoea and the effect of genetic variants 7
Sucrase-isomaltase genotype and response to a starch-reduced and sucrose-reduced diet in IBS-D patients 6
The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndrome 6
Analysis of 1135 gut metagenomes identifies sex-specific resistome profiles 5
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations 5
Intestinal Barrier and Permeability in Health, Obesity and NAFLD 5
European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations 5
Local genetic variation of inflammatory bowel disease in Basque population and its effect in risk prediction 4
Identification of a Genetic Variation in ERAP1 Aminopeptidase that Prevents Human Cytomegalovirus miR-UL112-5p-Mediated Immunoevasion 4
Genetic analyses of treatment response in primary care IBS, a pilot study 4
A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn’s Disease and Human Gut Microbiome Composition 3
A pilot genome‐wide association study meta‐analysis of gastroparesis 3
Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis 3
A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis 3
Genetic Variants as Predictors of the Success of Colorectal Cancer Treatments 2
Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci 2
Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations 2
Serotonin type 3 receptor subunit gene polymorphisms associated with psychosomatic symptoms in irritable bowel syndrome: A multicenter retrospective study 2
Severe pathogenic variants of intestinal sucrase-isomaltase interact avidly with the wild type enzyme and negatively impact its function and trafficking 2
The serotonin receptor 3E variant is a risk factor for female IBS-D 2
A meta‐analysis of reflux genome‐wide association studies in 6750 Northern Europeans from the general population 2
Functional Analyses of the Crohn’s Disease Risk Gene LACC1 1
HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis 1
The prevalence and transcriptional activity of the mucosal microbiota of ulcerative colitis patients 1
Increased Expression of Toll-Like Receptors 4, 5, and 9 in Small Bowel Mucosa from Patients with Irritable Bowel Syndrome 1
Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea‐predominant irritable bowel syndrome 1
Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota 1
Effect of aspirin on the diagnostic accuracy of the faecal immunochemical test for colorectal advanced neoplasia 1
Mendelian randomisation shows diverticular disease and irritable bowel syndrome increase the risk of haemorrhoidal disease 1
Erratum: A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis 1
Genome-wide association analysis of diverticular disease points towards neuromuscular, connective tissue and epithelial pathomechanisms 1
Dynamics of the human gut microbiome in inflammatory bowel disease 1
Targeted UPLC-MS Metabolic Analysis of Human Faeces Reveals Novel Low-Invasive Candidate Markers for Colorectal Cancer 1
Stool frequency is associated with gut microbiota composition 1
Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes 1
High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis 1
Hypomorphic SI genetic variants are associated with childhood chronic loose stools 1
Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease 1
Factors related to the participation and detection of lesions in colorectal cancer screening programme-based faecal immunochemical test 1
Targeted Analysis of Serum Proteins Encoded at Known Inflammatory Bowel Disease Risk Loci 1
Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype 1
Neuropeptide S (NPS) variants modify the signaling and risk effects of NPS Receptor 1 (NPSR1) variants in asthma 1
Mutations in RAD21 Disrupt Regulation of APOB in Patients With Chronic Intestinal Pseudo-Obstruction 1
Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomisation study 1
Totale 1.082
Categoria #
all - tutte 15.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.561

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202281 0 0 0 0 0 0 0 0 46 0 33 2
2022/2023474 73 0 5 69 20 67 1 26 58 18 122 15
2023/2024532 40 55 61 50 40 45 16 86 44 18 26 51
2024/20259 9 0 0 0 0 0 0 0 0 0 0 0
Totale 1.096